Beryl Drugs Share Price | Beryl Drugs Stock Screener
BERLDRG
Pharmaceuticals
Share Price BSE
₹20.10
▲
0.00 (0.00%)
As of May 20, 2026, the Beryl Drugs share price (BSE: BERLDRG) is ₹20.10, unchanged from the previous close, with shares trading between ₹20.10 and ₹20.15, and a 52-week range of ₹16.87–₹28.09.
Check BERLDRG 52-week chart for the annual price range and momentum.
Use the Beryl Drugs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Beryl Drugs Market Cap
₹10.73 Cr.
BERLDRG P/E Ratio (TTM)
-
Beryl Drugs P/B Ratio
1.11
EPS (TTM)
₹1.14
Dividend Yield
-
Debt to Equity
0.50
BERLDRG 52 Week High
₹28.09
Beryl Drugs 52 Week Low
₹16.87
Operating Margin
-
Profit Margin
-
BERLDRG Revenue (TTM)
₹19.00
EBITDA
₹2.00
Net Income
-
Total Assets
₹16.00
Total Equity
₹10.00
Beryl Drugs Share Price Chart
Screen Beryl Drugs share price with an interactive chart. Analyse BERLDRG price trends and volatility across different timeframes.
Beryl Drugs Company Profile - Fundamental Screener
Screen Beryl Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BERLDRG shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE415H01017
Beryl Drugs Balance Sheet Screener
Screen BERLDRG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 16 | 18 | 18 | 18 | 19 | 17 | 15 | 11 | 10 | 10 |
| Current Assets | 9 | 10 | 10 | 11 | 10 | 8 | 5 | 7 | 7 | 6 |
| Fixed Assets | 6 | 6 | 6 | 6 | 8 | 9 | 2 | 2 | 2 | 2 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 3 | 3 | 2 | 3 | 3 | 2 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 10 | 9 | 8 | 7 | 8 | 8 | 8 | 7 | 6 | 7 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 4 | 4 | 3 | 2 | 3 | 3 | 2 | 2 | 1 | 2 |
Beryl Drugs Income Statement Screener - Profit & Revenue Analysis
Screen Beryl Drugs income statement and profit fundamentals.
Analyze BERLDRG quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Beryl Drugs share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19 | 23 | 27 | 27 | 15 | 14 | 13 | 13 | 16 | 11 | 14 | 14 |
| Expenses | 18 | 20 | 25 | 25 | 14 | 13 | 12 | 12 | 14 | 11 | 13 | 13 |
| EBITDA | 2 | 3 | 3 | 2 | 1 | 2 | 1 | 1 | 2 | 0 | 1 | 1 |
| Operating Profit % | 0.00% | 6.00% | 9.00% | 7.00% | 3.00% | 10.00% | 7.00% | 8.00% | 7.00% | -1.00% | 4.00% | 6.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| Interest | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 1 | 1 | -1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 1 | 1 | -1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| EPS | 0.00 | 1.14 | 1.52 | 1.51 | -1.30 | 0.47 | 0.09 | 1.16 | 1.96 | -0.88 | 0.33 | 0.17 |
Beryl Drugs Cash Flow Screener - Liquidity Fundamentals
Screen BERLDRG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 3 | 1 | 3 | 0 | 0 | 0 | 3 | 0 | 0 | 0 |
| Investing Activities | 0 | -1 | -1 | 1 | 0 | -2 | -5 | 0 | 0 | 0 |
| Financing Activities | -2 | 0 | -1 | 0 | -1 | 2 | 2 | 0 | 0 | 0 |
| Net Cash Flow | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 0 |
Beryl Drugs Shareholding Pattern Screener
See Beryl Drugs shareholding pattern with promoter, FII, and DII holdings.
Check Beryl Drugs promoter holding and ownership changes for BERLDRG on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 27.48% | 26.38% | 26.38% | 26.38% | 26.38% | 26.38% | 26.38% | 26.38% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 64.94% | 68.53% | 68.69% | 68.71% | 66.25% | 66.26% | 68.06% | 67.92% |
| Other Holding | 7.59% | 5.08% | 4.93% | 4.91% | 7.37% | 7.35% | 5.55% | 5.70% |
| Shareholder Count | 7,349 | 7,431 | 7,415 | 7,446 | 7,409 | 7,257 | 7,325 | 7,364 |
Beryl Drugs Share Dividend Screener - Share Yield Analysis
Check Beryl Drugs dividend history with payout and yield data.
View Beryl Drugs dividend details including ex-dates and amounts for BERLDRG stock.
Beryl Drugs Stock Index Membership
See which indices include Beryl Drugs stock.
Check BERLDRG index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Beryl Drugs Market Events Screener - Corporate Actions
Get Beryl Drugs corporate actions including splits, bonuses, and buybacks.
Check Beryl Drugs stock events that may affect BERLDRG share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -1.84% | ||
| Annual General Meeting | NA | -16.04% | ||
| 2026-05-11 | 2026-05-11 | Extraordinary General Meeting | NA | 6.79% |
| 2026-03-16 | 2026-03-16 | Extraordinary General Meeting | NA | -6.91% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | -1.32% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 1.70% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -3.22% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -4.64% |
| 2025-02-08 | 2025-02-08 | Quarterly Result Announcement | NA | -6.59% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 0.30% |
Beryl Drugs Competitors Screener - Peer Comparison
Screen BERLDRG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 450,643 | 40.81 | 54,729 | 9.71% | 10,980 | 64.89 |
| Divis Laboratories | 179,470 | 74.13 | 9,712 | 18.67% | 2,191 | 64.06 |
| Torrent Pharmaceuticals | 149,109 | 65.68 | 11,539 | 6.99% | 1,911 | 58.52 |
| Cipla | 115,682 | 30.09 | 27,712 | -2.46% | 3,783 | 69.78 |
| Dr Reddys Laboratories | 111,567 | 26.16 | 33,593 | -0.44% | 3,998 | 59.87 |
| Lupin | 104,032 | 19.28 | 27,488 | 19.98% | 5,345 | 46.11 |
| Mankind Pharma | 103,325 | 56.36 | 12,744 | 20.90% | 2,007 | 73.37 |
| Zydus Life Science | 101,801 | 19.85 | 23,511 | 18.55% | 4,615 | 69.47 |
| Aurobindo Pharma | 87,806 | 25.16 | 32,346 | 9.43% | 3,484 | 73.83 |
| Laurus Labs | 71,455 | 79.78 | 6,813 | 21.03% | 884 | 80.26 |
Beryl Drugs Company Announcements - News Screener
Screen BERLDRG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-20 | PROCEEDINGS OF EGM | - |
| 2026-05-19 | ANNOUNCEMENT UBDER REGULATION 44 VOTING RESULTS OF EGM HELD ON 11TH MAY 2026 | - |
| 2026-05-19 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-05-18 | ANNOUNCEMENT UNDER REGULATION 30 | - |
| 2026-05-18 | Announcement Under Regulation 30 | - |
| 2026-05-18 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-18 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-18 | Shareholder Meeting / Postal Ballot-Outcome of EGM | - |
| 2026-04-13 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-04-08 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-08 | COMPLIANCE CERTIFICATE | - |
| 2026-04-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-06 | Compliance-57 (5) : intimation after the end of quarter | - |
| 2026-04-06 | COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) FOR THE YEAR ENDED 31.03.2026 | - |
| 2026-04-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-01 | FIXES RECORD DATE FOR THE PURPOSE OF EXTRA ORDINARY GENERAL MEETING OF THE COMPANY | - |
| 2026-04-01 | INTIMATION OF E-VOTING DATES FOR THE PURPOSE OF EOGM OF THE COMPANY | - |
| 2026-04-01 | EGM ON 11TH MAY 2026 AT 11:00 A.M | - |
| 2026-04-01 | FIXES RECORD DATE FOR THE PURPOSE OF EXTRA ORDINARY GENERAL MEETING | - |
| 2026-04-01 | Board Meeting Outcome for OUTCOME OF BOARD MEETING | - |